Picture of Oncoinvent ASA logo

ONCIN Oncoinvent ASA Cashflow Statement

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Oncoinvent ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-309-302-190-139-155
Depreciation
Non-Cash Items-0.3892.83-1.49-2.7820.7
Other Non-Cash Items
Changes in Working Capital5.110.2-33.4-11.6-8.08
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-303-288-225-153-131
Capital Expenditures-0.119
Purchase of Fixed Assets
Other Investing Cash Flow Items3.133.253.063.694.8
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities3.133.253.063.694.68
Financing Cash Flow Items-0.069-0.007-37-8.83-19.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities162.9225130119
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-285-2865.62-16.344